These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8176169)

  • 41. Longitudinal cohort study of patients with birdshot chorioretinopathy II: color vision at baseline.
    Holland GN; Shah KH; Monnet D; Brezin AP; Yu F; Nusinowitz S; Levinson RD
    Am J Ophthalmol; 2006 Dec; 142(6):1013-8. PubMed ID: 17157585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A large field Panel D-15 test for low vision patients.
    Uvijls A; Leroy BP; Leys M; De Rouck A; Kestelyn P
    Bull Soc Belge Ophtalmol; 1998; 270():57-65. PubMed ID: 9919782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Numerical confusion errors in ishihara testing: findings from a population-based study.
    Cosstick M; Robaei D; Rose K; Rochtchina E; Mitchell P
    Am J Ophthalmol; 2005 Jul; 140(1):154-6. PubMed ID: 16038669
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Neurophysiological basis and clinical tests for assessment of X-linked color vision deficiencies in school children].
    Rigaudière F; Leid J; Viénot F; Le Gargasson JF
    J Fr Ophtalmol; 2006 Jan; 29(1):87-102. PubMed ID: 16465130
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Measurement set-up for estimation of colour discrimination thresholds of colour vision deficiencies and while wearing coloured filters].
    Schürer M; Walter A; Eppig T; Brünner H; Langenbucher A
    Klin Monbl Augenheilkd; 2009 Jul; 226(7):546-54. PubMed ID: 19548186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Color vision: a sensitive indicator of exposure to neurotoxins.
    Gobba F
    Neurotoxicology; 2000 Oct; 21(5):857-62. PubMed ID: 11130291
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Comparative follow-up study of unselected male population with congenital defective color vision from inland and Mediterranean areas of Croatia].
    Rogosić V; Bojić L; Karaman K; Rogosić LV; Titlić M; Poljak NK; Plestina-Borjan I; Smerdelj A; Duplancić D; Alpeza-Dunato Z
    Acta Med Croatica; 2011 Mar; 65(1):19-24. PubMed ID: 21568070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evolution of color vision loss induced by occupational exposure to chemicals.
    Gobba F; Cavalleri A
    Neurotoxicology; 2000 Oct; 21(5):777-81. PubMed ID: 11130282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testability of a color vision screening test in a population with mental retardation.
    Erickson GB; Block SS
    J Am Optom Assoc; 1999 Dec; 70(12):758-63. PubMed ID: 10676072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Standardized evaluation of red, green and blue perception. Comparison between color arrangement and computer-assisted test procedures].
    Nimsgern C; Krastel H; Auffarth GU; Eggers I; Lang H
    Ophthalmologe; 1998 Aug; 95(8):559-63. PubMed ID: 9782733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A new color vision test to differentiate congenital and acquired color vision defects.
    Shin YJ; Park KH; Hwang JM; Wee WR; Lee JH
    Ophthalmology; 2007 Jul; 114(7):1341-7. PubMed ID: 17296231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency of colour vision deficiencies in melanoma patients: results of a prospective comparative screening study with the Farnsworth panel D 15 test including 300 melanoma patients and 100 healthy controls.
    Pföhler C; Tschöp S; König J; Rass K; Tilgen W
    Melanoma Res; 2006 Oct; 16(5):413-21. PubMed ID: 17013090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Discordance between results from the Ishihara atlas and the Nagel type I anomaloscope in a certain number of hereditary dyschromasia patients].
    Cvetnić B; Peić M
    Bull Mem Soc Fr Ophtalmol; 1985; 96():361-4. PubMed ID: 3874668
    [No Abstract]   [Full Text] [Related]  

  • 54. Tilted disc syndrome and colour vision.
    Vuori ML; Mäntyjärvi M
    Acta Ophthalmol Scand; 2007 Sep; 85(6):648-52. PubMed ID: 17403021
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anomaloscope examination: scotopization (the luminance fall).
    Pinckers A
    Acta Ophthalmol Scand; 1999 Oct; 77(5):552-4. PubMed ID: 10551299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Color vision assessment: fail rates of two versions of the Farnsworth lantern test.
    Cole BL; Lian KY; Lakkis C
    Aviat Space Environ Med; 2006 Jun; 77(6):624-30. PubMed ID: 16780241
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Color vision and occupational chemical exposures: I. An overview of tests and effects.
    Iregren A; Andersson M; Nylén P
    Neurotoxicology; 2002 Dec; 23(6):719-33. PubMed ID: 12520762
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Representation of normal and pathologic macular color vision].
    Ionica V; Gastaud P
    J Fr Ophtalmol; 1999 Feb; 22(1):53-6. PubMed ID: 10221192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Final clarification of Goethe's findings in the examination of color blind patients].
    Jaeger W
    Klin Monbl Augenheilkd; 1989 Dec; 195(6):382-7. PubMed ID: 2695690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chromaticity discrimination in protan and deutan heterozygotes.
    Verriest G
    Mod Probl Ophthalmol; 1974; 13(0):262-4. PubMed ID: 4548142
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.